MYC Gene Mutation Recruiting Phase 1 / 2 Trials for Methotrexate (DB00563)

IndicationStatusPhase
DBCOND0077472 (MYC Gene Mutation)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs